期刊简介
《临床医学工程》杂志是经国家新闻出版总署批准（新出报刊〔2008〕946号），由国家医疗保健器具工程技术研究中心（广东省医疗器械研究所）主办的学术类科技期刊，以“服务于临床医务工作者和医学工程人员”为办刊宗旨。国内统一刊号：CN 44-1655/R，国际标准刊号：ISSN 1674-4659；国内邮发代号：46-130，国外发行代号：M8885。 《临床医学工程》刊名由第十一届全国人大常委会副委员长，九三学社中央主席，中国科学技术协会主席，北京大学医学部主任、教授，中国科学院院士韩启德题写。 《临床医学工程》为“中国学术期刊综合评价数据库统计源期刊”（编号：ZY0849），中国知网（CNKI）全文收录期刊；“中国核心期刊（遴选）数据库收录期刊”（编号GD084），万方数据-数字化期刊群（Wanfangdata）全文收录期刊；“中文科技期刊数据库（全文版）收录期刊”（编号06－1063）；中国人民解放军医学图书馆“中国生物医学期刊引文数据库”收录期刊；Airiti Library（台湾华艺线上图书馆）全文收录期刊。据中国科学技术信息研究所、万方数据股份有限公司编制的《2013年版中国期刊引证报告》，《临床医学工程》杂志影响因子（Impact Factor，IF）为0.526。 刊期及出版日：月刊，每月15日出版 国内发行：广东省报刊发行局 订阅零售：全国各地邮局（所） 国外发行：中国国际图书贸易总公司 本刊文章不接排，不转版，方便查阅，方便复印。 欢迎临床医护、医学工程等人士投稿。 优先刊登基金课题论文，硕士和博士研究生毕业论文。
SCI论文投稿全程模板实例
时间：2024-03-22 09:31:25
SCI论文投稿全程模板主要包括以下几个部分：投稿信（Cover Letter）、论文正文、作者信息和致谢等。下面将详细介绍这些部分，并给出实例说明。
一、投稿信（Cover Letter）
投稿信是向编辑介绍论文内容和作者情况的重要文件，也是论文投稿过程中必不可少的一部分。在投稿信中，作者需要简要介绍论文的研究背景、目的、方法、结果和结论，同时说明论文的创新性和重要性。此外，作者还需要提供自己的联系方式和作者简介等信息。
以下是一个投稿信的实例：
Dear Editor,
We are pleased to submit our manuscript entitled "XXX" for consideration for publication in your journal. In this study, we aimed to investigate the effect of XXX on XXX in a mouse model of XXX. We found that XXX significantly reduced the levels of XXX and improved the symptoms of XXX in mice. These findings suggest that XXX may be a potential therapeutic agent for the treatment of XXX.
We believe that our study is of great interest to the readers of your journal and will contribute significantly to the field of XXX research. We have carefully checked the manuscript for typographical and grammatical errors, and have ensured that the data presented are accurate and reproducible.
Please find attached the manuscript files in Word and PDF formats, as well as the figures and tables in separate files. We have also included a list of potential reviewers for your consideration. However, we would like to note that we have no conflicts of interest with any of the reviewers listed.
Thank you for considering our manuscript for publication in your journal. We look forward to hearing from you soon.
Sincerely,
[Your Name]
[Your Affiliation]
[Your Email Address]
二、论文正文
论文正文是SCI论文投稿的核心部分，包括标题、摘要、关键词、引言、方法、结果、讨论和结论等部分。在撰写论文正文时，作者需要遵循学术规范和论文写作要求，确保论文内容准确、清晰、有条理。
以下是一个论文正文的实例（仅包含部分部分）：
Title: The effect of XXX on XXX in a mouse model of XXX
Abstract: In this study, we investigated the effect of XXX on XXX in a mouse model of XXX. We found that XXX significantly reduced the levels of XXX and improved the symptoms of XXX in mice. These findings suggest that XXX may be a potential therapeutic agent for the treatment of XXX.
Keywords: XXX; XXX; Mouse model; Therapeutic agent
Introduction: XXX is a common disease that affects millions of people worldwide. Current treatments for XXX are limited and often associated with side effects. Therefore, there is an urgent need to develop new therapeutic agents for the treatment of XXX. In this study, we aimed to investigate the effect of XXX on XXX in a mouse model of XXX.
Methods: We used a mouse model of XXX to investigate the effect of XXX on XXX. Mice were randomly divided into two groups: a control group and a treatment group. The treatment group received XXX at a dose of XXX mg/kg/day for XXX days. All mice were sacrificed at the end of the experiment, and the levels of XXX were measured using XXX assay.
Results: We found that the levels of XXX were significantly reduced in the treatment group compared to the control group (Figure 1). In addition, the symptoms of XXX were also improved in the treatment group (Table 1).
Discussion: Our findings suggest that XXX may be a potential therapeutic agent for the treatment of XXX. The reduction in the levels of XXX and improvement in the symptoms of XXX observed in our study are consistent with previous reports suggesting that XXX has anti-inflammatory and antioxidant properties. However, further studies are needed to confirm the efficacy and safety of XXX in humans.
Conclusion: In conclusion, we found that XXX significantly reduced the levels of XXX and improved the symptoms of XXX in a mouse model of XXX. These findings suggest that XXX may be a potential therapeutic agent for the treatment of XXX and warrant further investigation in clinical trials.
（注：以上实例中的XXX需要根据实际情况进行替换。）
三、作者信息和致谢
在论文正文的最后，作者需要提供详细的作者信息和致谢。作者信息包括作者的姓名、单位、联系方式等；致谢则是对在论文撰写过程中给予帮助和支持的人或机构表示感谢。
以下是一个作者信息和致谢的实例：
Authors: [Your Name], [Co-author's Name], [Another Co-author's Name]
Affiliations: [Your Affiliation], [Co-author's Affiliation], [Another Co-author's Affiliation]
Contact Information: [Your Email Address], [Your Phone Number]
Acknowledgments: We would like to thank [Name of Funding Agency] for providing financial support for this study. We also thank [Name of Individual] for their assistance with data collection and analysis. Finally, we would like to express our gratitude to the anonymous reviewers for their valuable comments and suggestions on the manuscript.